Jefferies Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Jefferies Financial Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.1K	Hold	17,000	–	–	﹤0.01%	1648
2025 Q4	$55.3K	Hold	17,000	–	–	﹤0.01%	1753
2025 Q3	$48.8K	Hold	17,000	–	–	﹤0.01%	1390
2025 Q2	$41K	Hold	17,000	–	–	﹤0.01%	1205
2025 Q1	$37.6K	Hold	17,000	–	–	﹤0.01%	1527
2024 Q4	$92.7K	Sell	17,000 -55,693	-77%	-$358K	﹤0.01%	1463
2024 Q3	$604K	Buy	72,693 +55,693	+328%	+$481K	﹤0.01%	931
2024 Q2	$122K	Sell	17,000 -27,500	-62%	-$237K	﹤0.01%	1274
2024 Q1	$386K	Buy	44,500 +27,500	+162%	+$186K	﹤0.01%	1132
2023 Q4	$111K	Buy	17,000 +1,753	+11%	+$11.3K	﹤0.01%	1536
2023 Q3	$152K	Buy	+15,247	New	+$167K	﹤0.01%	1392

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Financial Group's MRVI Position: Q1 2026 in Review

Jefferies Financial Group held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 17,000 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Jefferies Financial Group first reported a position in MRVI in Q3 2023 and has held it in 11 quarters since. The position peaked at $604K in Q3 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Jefferies Financial Group held 17,000 shares of Maravai LifeSciences worth $48.1K as of Q1 2026.
Jefferies Financial Group left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1648 holding.
Jefferies Financial Group first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 11 quarters since.
Jefferies Financial Group's Maravai LifeSciences position peaked at $604K in Q3 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.